Ashly Hindle

613 total citations
25 papers, 425 citations indexed

About

Ashly Hindle is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Ashly Hindle has authored 25 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Physiology and 7 papers in Neurology. Recurrent topics in Ashly Hindle's work include Alzheimer's disease research and treatments (6 papers), Neuroblastoma Research and Treatments (6 papers) and Retinoids in leukemia and cellular processes (6 papers). Ashly Hindle is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Neuroblastoma Research and Treatments (6 papers) and Retinoids in leukemia and cellular processes (6 papers). Ashly Hindle collaborates with scholars based in United States, Australia and Poland. Ashly Hindle's co-authors include Sudhir Kshirsagar, P. Hemachandra Reddy, Jangampalli Adi Pradeepkiran, C. Patrick Reynolds, Monish Ram Makena, Thinh H. Nguyen, Min H. Kang, Murali Vijayan, Chhanda Bose and Sharda P. Singh and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Ashly Hindle

24 papers receiving 423 citations

Peers

Countries citing papers authored by Ashly Hindle

Since Specialization

Citations

This map shows the geographic impact of Ashly Hindle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashly Hindle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashly Hindle more than expected).

Fields of papers citing papers by Ashly Hindle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashly Hindle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashly Hindle. The network helps show where Ashly Hindle may publish in the future.

Co-authorship network of co-authors of Ashly Hindle

This figure shows the co-authorship network connecting the top 25 collaborators of Ashly Hindle. A scholar is included among the top collaborators of Ashly Hindle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashly Hindle. Ashly Hindle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The synergistic interplay between vitamin A, dietary fiber, and the microbiota-gut-brain axis: a potential mechanism for preventing Alzheimer’s disease 2025 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·(unknown), G. Lindsay McCrea, (unknown), (unknown), Sean Daly, (unknown), (unknown), Charlie Zhang, Matthew C. Hernandez, Ashly Hindle, Aric F. Logsdon, Jody Lawrence	0
2	The role of RLIP76 in oxidative stress and mitochondrial dysfunction: Evidence based on autopsy brains from Alzheimer's disease patients 2023 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Chhanda Bose, Sudhir Kshirsagar, Murali Vijayan, Subodh Kumar, Sharda P. Singh, Ashly Hindle, P. Hemachandra Reddy	6
3	The Contribution of Hippocampal All-Trans Retinoic Acid (ATRA) Deficiency to Alzheimer’s Disease: A Narrative Overview of ATRA-Dependent Gene Expression in Post-Mortem Hippocampal Tissue 2023 ·Antioxidants ·(unknown), Ashly Hindle, J. Josh Lawrence	4
4	Rlip overexpression reduces oxidative stress and mitochondrial dysfunction in Alzheimer's disease: Mechanistic insights 2023 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·P. Hemachandra Reddy, Sudhir Kshirsagar, Chhanda Bose, Jangampalli Adi Pradeepkiran, Ashly Hindle, Sharda P. Singh, Arubala P. Reddy	7
5	Rlip Reduction Induces Oxidative Stress and Mitochondrial Dysfunction in Mutant Tau-Expressed Immortalized Hippocampal Neurons: Mechanistic Insights 2023 ·Cells ·P. Hemachandra Reddy, Sudhir Kshirsagar, Chhanda Bose, Jangampalli Adi Pradeepkiran, Ashly Hindle, Sharda P. Singh, Arubala P. Reddy, (unknown)	7
6	A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease 2022 ·Cells ·Sudhir Kshirsagar, (unknown), Jangampalli Adi Pradeepkiran, Ashly Hindle, Murali Vijayan, (unknown), Subodh Kumar, Arubala P. Reddy, P. Hemachandra Reddy	31
7	Rlip Protein: A Potential Target for COVID-19 2022 ·Journal of Community Hospital Internal Medicine Perspectives ·Jonathan Kopel, Sharda P. Singh, Ashly Hindle, (unknown), Chhanda Bose, Sanjay Awasthi	1
8	Are mitophagy enhancers therapeutic targets for Alzheimer’s disease? 2022 ·Biomedicine & Pharmacotherapy ·Jangampalli Adi Pradeepkiran, Ashly Hindle, Sudhir Kshirsagar, P. Hemachandra Reddy	49
9	Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease? 2022 ·International Journal of Molecular Sciences ·Ashly Hindle, Sharda P. Singh, Jangampalli Adi Pradeepkiran, Chhanda Bose, Murali Vijayan, Sudhir Kshirsagar, Neha Sawant, P. Hemachandra Reddy	11
10	Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer’s Disease 2022 ·Cells ·Sudhir Kshirsagar, (unknown), Ashly Hindle, Subodh Kumar, Murali Vijayan, Jangampalli Adi Pradeepkiran, Arubala P. Reddy, (unknown), P. Hemachandra Reddy	18
11	ALT neuroblastoma chemoresistance due to telomere dysfunction–induced ATM activation is reversible with ATM inhibitor AZD0156 2021 ·Science Translational Medicine ·(unknown), Ahsan Farooqi, Thinh H. Nguyen, (unknown), Ashly Hindle, (unknown), Monish Ram Makena, (unknown), Joanne Wilson, Aaron Smith, Venkatesh Pilla Reddy, Elaine Cadogan, Stephen T. Durant, C. Patrick Reynolds	40
12	Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells 2021 ·Cancers ·Chhanda Bose, Ashly Hindle, Ji‐Hyun Lee, Jonathan Kopel, Sahil Tonk, Philip Palade, Sharad S. Singhal, Sanjay Awasthi, Sharda P. Singh	7
13	Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis 2021 ·Cancers ·Sharda P. Singh, Ji‐Hyun Lee, Chhanda Bose, Hongzhi Li, Yate‐Ching Yuan, Ashly Hindle, Sharad S. Singhal, Jonathan Kopel, Philip Palade, Catherine Jones, Rakhshanda Layeequr Rahman, Sanjay Awasthi	4
14	Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma 2020 ·Cancer Research ·(unknown), Gonzalo López, Ahsan Farooqi, Karina L. Conkrite, Thinh H. Nguyen, (unknown), Apexa Modi, Jo Lynne Rokita, Eduardo Urias, Ashly Hindle, (unknown), (unknown), (unknown), (unknown), Meredith S. Irwin, Shengping Yang, David A. Wheeler, John M. Maris, Sharon J. Diskin, C. Patrick Reynolds	56
15	MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma 2020 ·Cell Death and Disease ·Sung‐Jen Wei, Thinh H. Nguyen, In‐Hyoung Yang, (unknown), Monish Ram Makena, (unknown), Ashly Hindle, Gloria Martı́nez, Shengping Yang, Hiroyuki Shimada, C. Patrick Reynolds, Min H. Kang	22
16	Topical 2′-Hydroxyflavanone for Cutaneous Melanoma 2019 ·Cancers ·Chhanda Bose, Sharda P. Singh, (unknown), (unknown), Sharad S. Singhal, Ji Hyun Lee, Philip Palade, (unknown), Somedeb Ball, Vijay S. Tonk, Ashly Hindle, Michelle Tarbox, Sanjay Awasthi	14
17	Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia 2018 ·Anti-Cancer Drugs ·Michael M. Song, Monish Ram Makena, Ashly Hindle, (unknown), Thinh H. Nguyen, (unknown), (unknown), Barry J. Maurer, Min H. Kang, C. Patrick Reynolds	11
18	Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell lines 2018 ·Pediatric Blood & Cancer ·Monish Ram Makena, (unknown), Thinh H. Nguyen, (unknown), (unknown), Ashly Hindle, Min H. Kang, C. Patrick Reynolds	4
19	Activity of MM-398, Nanoliposomal Irinotecan (nal-IRI), in Ewing's Family Tumor Xenografts Is Associated with High Exposure of Tumor to Drug and High SLFN11 Expression 2015 ·Clinical Cancer Research ·Min H. Kang, Jing Wang, Monish Ram Makena, (unknown), Nancy Paz, (unknown), Michael M. Song, Ruben I. Calderon, (unknown), Ashly Hindle, (unknown), Jonathan B. Fitzgerald, Daryl C. Drummond, Timothy J. Triche, C. Patrick Reynolds	85
20	Abstract 2616: Comparison of the cytotoxicity and increase of reactive oxygen species and dihydroceramides of fenretinide to its major metabolites (4-oxo- and 4-methoxyphenyl fenretinide) in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines 2015 ·Cancer Research ·Michael M. Song, Monish Ram Makena, Ashly Hindle, (unknown), Thinh H. Nguyen, (unknown), Barry J. Maurer, Min H. Kang, C. Patrick Reynolds	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact